跳至主要内容
临床试验/NCT04921293
NCT04921293招募中不适用

Comparison Between Endogenous and Exogenous Ketosis in Patients With Non-ischemic Chronic Heart Failure With Reduced Ejection Fraction

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran2 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2023年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
18
试验地点
2
主要终点
Ejection fraction Improvement

研究概览

简要总结

This randomized controlled trial will evaluate the effect of a ketogenic diet and/or exogenous administration of ketone bodies vs conventional diet on the ejection fraction of patients with non-ischemic chronic heart failure, measuring MRI biomarkers.

详细描述

Evidence in both animals and humans suggests ketosis could be beneficial for people living with chronic heart failure. To date, no study has compared endogenous vs exogenous ketosis in patients with chronic heart failure. We will randomize (with a 1:1:1 ratio) patients with a confirmed diagnosis of non-ischemic chronic heart failure to undergo one of the following:

    • A ketogenic diet (<50 gr of carbohydrates per day) incorporating current recommendations for heart failure (low sodium and liquids) for 10 days.
    • Standard diet incorporating current recommendations for heart failure (low sodium and liquids) and supplementation with exogenous ketones (ketone monoester) for 10 days.
    • Standard diet incorporating current recommendations for heart failure (low sodium and liquids) and supplementation with bitter taste placebo.

The endpoints will be assessed using cardiac MRI and blood biomarkers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ejection fraction <40% minimum 1 month.
  • No change in optimum treatment 1 month at least.

排除标准

  • Ischemic cardiopathy (Angio-tomography corroborated cut-point >50% obstruction, coronary angiography, or cardiac scintigraphy 6 months at least) or angina pectoris symptoms.
  • Reynaud syndrome
  • Metformin or SGLT-2 Inhibitors treatment, Low BMI, nutritional deficiencies.
  • Creatinin clearance <30ml/min or renal replacement therapy
  • MRI contraindications (prothesis, Unsupported pacemakers, claustrophobia, etc)
  • Reynaud phenomenon history

结局指标

主要结局

Ejection fraction Improvement

时间窗: 10 days

Estimated by cardiac MRI

次要结局

  • Liquid retention(10 days)
  • Blood biomarker(10 days)
  • Clinical severity(10 days)

研究者

发起方
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验